Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative. [electronic resource]
Producer: 19981105Description: 1291-300 p. digitalISSN:- 0269-9370
- AIDS Vaccines -- adverse effects
- Adult
- Amino Acid Sequence
- Antigens, CD -- analysis
- Cell Line, Transformed
- Enzyme-Linked Immunosorbent Assay
- Female
- HIV Antibodies -- blood
- HIV Envelope Protein gp120 -- adverse effects
- HIV Infections -- immunology
- HLA-B7 Antigen -- immunology
- Humans
- Intradermal Tests
- Lymphocyte Subsets -- immunology
- Lymphocytes -- immunology
- Male
- Middle Aged
- Molecular Sequence Data
- Neutralization Tests
- Pilot Projects
- RNA, Viral -- blood
- T-Lymphocytes, Cytotoxic -- immunology
- Vaccines, Synthetic -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.